Watchlist Price Alert

Kindred Biosciences Inc. (KIN)

NASDAQ: KIN · Real-Time Price · USD

9.25

0.01 (0.11%)

At close: Apr 24, 2025, 3:47 PM

Kindred Biosciences Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-21.8M	-61.39M	-49.69M	-30.88M	-22.5M
Depreciation & Amortization	4.68M	2.54M	805K	475K	155K
Stock-Based Compensation	7.59M	7.36M	6.28M	5.21M	3.63M
Other Working Capital	-3.89M	-5.86M	1.91M	1.85M	369K
Other Non-Cash Items	4.2M	-156K	-145K	189K	277K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-4.53M	-4.69M	-2.28M	3.13M	-341K
Operating Cash Flow	-9.86M	-56.34M	-45.03M	-21.88M	-18.78M
Capital Expenditures	-3.64M	-8.43M	-13.92M	-5.92M	-952K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-75.67M	-125.02M	-25.1M	-70.11M	-72.05M
Sales Maturities Of Investments	85M	85.63M	55.38M	73.36M	78.31M
Other Investing Acitivies	82K	5K	248K	n/a	n/a
Investing Cash Flow	5.77M	-47.82M	16.6M	-2.67M	5.31M
Debt Repayment	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	-247K	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-282K	63.84M	49.92M	52.67M	162K
Financial Cash Flow	-282K	63.84M	49.92M	52.67M	162K
Net Cash Flow	-4.37M	-40.32M	21.49M	28.13M	-13.3M
Free Cash Flow	-13.49M	-64.77M	-58.95M	-27.8M	-19.73M